Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Finch Therapeutics Group, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 51 | 53 | +2 |
| Shares | 11.5M | 10.6M | −978.9K (−8.5%) |
| Value | $115.0M | $53.1M | −$61.9M (−53.8%) |
New holders (4)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 1,336 | $7.00K | 0.00% |
| Amalgamated Bank | 942 | $5.00K | 0.00% |
| Amalgamated Financial Corp. | 942 | $5.00K | 0.00% |
| FMR LLC | 47 | $0 | 0.00% |
Sold out (2)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Millennium Management LLC | 12,642 | $126.0K |
| Lazard Asset Management LLC | 150 | $1.00K |